investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
Daniel W Cramer
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Rudolf Kaaks
German Cancer Research Center (HZ)
Heidelberg, Germany
Daniel W Cramer
Brigham and Women's Hospital
Boston, United States
Related projects
Celeste Leigh Pearce
Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives
Ovary
Pathology
Linda S Cook
Mitochondrial DNA and Ovarian Cancer Risk and Survival
Ovary
Pathology
Ernst Lengyel
Regulation of Adhesion and Proteolysis in Ovarian Cancer
Ovary
Pathology
Lesley M Butler
Urinary Metalloproteinases and Ovarian Cancer Risk in a Prospective Cohort
Ovary
Pathology
Scott H Kaufmann
Mayo Clinic SPORE in Ovarian Cancer
Ovary
Pathology
Thomas A Sellers
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
Ovary
Pathology
Multiple Myeloma Study / Histological Classification and Clinical Course of Surface Epithelial Ovarian Tumors in Abuja
Ovary
Pathology
Mary Anne Rossing
Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer
Ovary
Pathology
Andre Michael Lieber
Evaluation of Vectors Based on Group B Adenoviruses
Ovary
Pathology